Company Name: Mirna Therapeutics Inc.  

Mirna Therapeutics Inc. is a clinical-stage biopharmaceutical company. The company is engaged in the development of microRNA-based oncology therapeutics. The company’s lead product candidate is designed to mimic the natural occurring microRNA tumor suppressor miR-34.

Ticker Symbol: MIRN (NASDAQ)

Company Website:

Social Media: Mirna Therapeutics LinkedIn

Headquarters: Austin, TX